Using Genetics to Optimize Treatment of Opiate Addiction – Current and Emerging Genetic Markers
Learning Areas:Clinical medicine applied in public health
Public health or related research
Identify genetic markers that may be used to optimize treatment of opiate addiction
Keyword(s): Drug Abuse Treatment, Research
Qualified on the content I am responsible for because: Naissan Hussainzada is Director, Pharmacogenetic Testing Clinical Strategy, Millennium Health. Principal Investigator, Millennium Research Institute. She is an educator and researcher in the areas of pharmacology and translational pharmacogenetics, with extensive experience lecturing at the regional and national level on topics including addiction, mental health disorders and chronic pain. I am currently conducting research evaluating associations between genetic markers and clinical outcomes in patients receiving therapy for various chronic conditions, including addiction.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.